GSK PLC (GSK) RNS Announcements | Ticker

⌘K

GSK PLC (GSK) RNS Announcements | Ticker | Ticker

Date	Time	Date	TitleTitle (filtered)
16/02/26	15:30:00	16 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
16/02/26	15:30:00	16 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
16/02/26	15:30:00	16 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
11/02/26	15:30:01	11 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
11/02/26	15:30:01	11 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
11/02/26	15:30:01	11 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
11/02/26	15:30:00	11 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
10/02/26	07:00:13	10 Feb 2026	China CDE accepts Arexvy adults 60+ application	China CDE accepts Arexvy adults 60+ application
09/02/26	15:30:00	9 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
06/02/26	10:30:00	6 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
06/02/26	07:00:09	6 Feb 2026	Nucala COPD approved by the European Commission	Nucala COPD approved by the European Commission
05/02/26	15:30:00	5 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
04/02/26	07:00:03	4 Feb 2026	Final Results	Final Results
02/02/26	15:00:00	2 Feb 2026	Total Voting Rights	Total Voting Rights
26/01/26	07:00:07	26 Jan 2026	European Commission approves Arexvy for adults 18+	European Commission approves Arexvy for adults 18+
20/01/26	07:05:00	20 Jan 2026	GSK to acquire RAPT Therapeutics	GSK to acquire RAPT Therapeutics
20/01/26	07:00:07	20 Jan 2026	Agreement on changes to ViiV minority shareholding	Agreement on changes to ViiV minority shareholding
16/01/26	15:30:00	16 Jan 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
15/01/26	15:30:00	15 Jan 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
13/01/26	15:30:01	13 Jan 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
07/01/26	07:05:00	7 Jan 2026	EC approval of Shingrix PFS	EC approval of Shingrix PFS
07/01/26	07:00:04	7 Jan 2026	Positive phase 3 data for GSK's bepirovirsen	Positive phase 3 data for GSK's bepirovirsen
06/01/26	07:00:05	6 Jan 2026	Exdensur approved in Japan	Exdensur approved in Japan
05/01/26	15:30:00	5 Jan 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
05/01/26	15:00:00	5 Jan 2026	Total Voting Rights	Total Voting Rights
05/01/26	07:00:07	5 Jan 2026	Nucala for adults with COPD approved in China	Nucala for adults with COPD approved in China
22/12/25	15:30:01	22 Dec 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
22/12/25	07:00:08	22 Dec 2025	GSK to lower drug prices and expand access in US	GSK to lower drug prices and expand access in US
22/12/25	07:00:04	22 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
19/12/25	07:00:03	19 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
18/12/25	07:00:04	18 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
17/12/25	07:00:10	17 Dec 2025	Exdensur (depemokimab ulla) approved by US FDA	Exdensur (depemokimab ulla) approved by US FDA
17/12/25	07:00:07	17 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
16/12/25	07:00:08	16 Dec 2025	Exdensur (depemokimab) UK MHRA approval	Exdensur (depemokimab) UK MHRA approval
16/12/25	07:00:05	16 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
15/12/25	07:00:05	15 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
12/12/25	13:50:15	12 Dec 2025	Nucala receives positive CHMP opinion for COPD	Nucala receives positive CHMP opinion for COPD
12/12/25	13:41:03	12 Dec 2025	Depemokimab receives positive CHMP opinion	Depemokimab receives positive CHMP opinion
12/12/25	07:00:08	12 Dec 2025	Positive CHMP opinion on Arexvy for all adults 18+	Positive CHMP opinion on Arexvy for all adults 18+
12/12/25	07:00:04	12 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
11/12/25	17:54:05	11 Dec 2025	Blujepa approved in US for gonorrhoea indication	Blujepa approved in US for gonorrhoea indication
11/12/25	15:30:00	11 Dec 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
11/12/25	09:00:00	11 Dec 2025	Block Listing Application	Block Listing Application
11/12/25	07:00:05	11 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
10/12/25	07:00:09	10 Dec 2025	GSK'227 US FDA Orphan Drug Designation in SCLC	GSK'227 US FDA Orphan Drug Designation in SCLC
10/12/25	07:00:03	10 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
09/12/25	15:30:00	9 Dec 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
09/12/25	07:00:04	9 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
08/12/25	07:00:06	8 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
05/12/25	07:00:05	5 Dec 2025	Transaction in Own Shares	Transaction in Own Shares

Showing 101–150 of 998 announcements

Date	Time	Date	TitleTitle (filtered)
16/02/26	15:30:00	16 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
16/02/26	15:30:00	16 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
16/02/26	15:30:00	16 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
11/02/26	15:30:01	11 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
11/02/26	15:30:01	11 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
11/02/26	15:30:01	11 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
11/02/26	15:30:00	11 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
10/02/26	07:00:13	10 Feb 2026	China CDE accepts Arexvy adults 60+ application	China CDE accepts Arexvy adults 60+ application
09/02/26	15:30:00	9 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
06/02/26	10:30:00	6 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
06/02/26	07:00:09	6 Feb 2026	Nucala COPD approved by the European Commission	Nucala COPD approved by the European Commission
05/02/26	15:30:00	5 Feb 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
04/02/26	07:00:03	4 Feb 2026	Final Results	Final Results
02/02/26	15:00:00	2 Feb 2026	Total Voting Rights	Total Voting Rights
26/01/26	07:00:07	26 Jan 2026	European Commission approves Arexvy for adults 18+	European Commission approves Arexvy for adults 18+
20/01/26	07:05:00	20 Jan 2026	GSK to acquire RAPT Therapeutics	GSK to acquire RAPT Therapeutics
20/01/26	07:00:07	20 Jan 2026	Agreement on changes to ViiV minority shareholding	Agreement on changes to ViiV minority shareholding
16/01/26	15:30:00	16 Jan 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
15/01/26	15:30:00	15 Jan 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
13/01/26	15:30:01	13 Jan 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
07/01/26	07:05:00	7 Jan 2026	EC approval of Shingrix PFS	EC approval of Shingrix PFS
07/01/26	07:00:04	7 Jan 2026	Positive phase 3 data for GSK's bepirovirsen	Positive phase 3 data for GSK's bepirovirsen
06/01/26	07:00:05	6 Jan 2026	Exdensur approved in Japan	Exdensur approved in Japan
05/01/26	15:30:00	5 Jan 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
05/01/26	15:00:00	5 Jan 2026	Total Voting Rights	Total Voting Rights
05/01/26	07:00:07	5 Jan 2026	Nucala for adults with COPD approved in China	Nucala for adults with COPD approved in China
22/12/25	15:30:01	22 Dec 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
22/12/25	07:00:08	22 Dec 2025	GSK to lower drug prices and expand access in US	GSK to lower drug prices and expand access in US
22/12/25	07:00:04	22 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
19/12/25	07:00:03	19 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
18/12/25	07:00:04	18 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
17/12/25	07:00:10	17 Dec 2025	Exdensur (depemokimab ulla) approved by US FDA	Exdensur (depemokimab ulla) approved by US FDA
17/12/25	07:00:07	17 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
16/12/25	07:00:08	16 Dec 2025	Exdensur (depemokimab) UK MHRA approval	Exdensur (depemokimab) UK MHRA approval
16/12/25	07:00:05	16 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
15/12/25	07:00:05	15 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
12/12/25	13:50:15	12 Dec 2025	Nucala receives positive CHMP opinion for COPD	Nucala receives positive CHMP opinion for COPD
12/12/25	13:41:03	12 Dec 2025	Depemokimab receives positive CHMP opinion	Depemokimab receives positive CHMP opinion
12/12/25	07:00:08	12 Dec 2025	Positive CHMP opinion on Arexvy for all adults 18+	Positive CHMP opinion on Arexvy for all adults 18+
12/12/25	07:00:04	12 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
11/12/25	17:54:05	11 Dec 2025	Blujepa approved in US for gonorrhoea indication	Blujepa approved in US for gonorrhoea indication
11/12/25	15:30:00	11 Dec 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
11/12/25	09:00:00	11 Dec 2025	Block Listing Application	Block Listing Application
11/12/25	07:00:05	11 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
10/12/25	07:00:09	10 Dec 2025	GSK'227 US FDA Orphan Drug Designation in SCLC	GSK'227 US FDA Orphan Drug Designation in SCLC
10/12/25	07:00:03	10 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
09/12/25	15:30:00	9 Dec 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
09/12/25	07:00:04	9 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
08/12/25	07:00:06	8 Dec 2025	Transaction in Own Shares	Transaction in Own Shares
05/12/25	07:00:05	5 Dec 2025	Transaction in Own Shares	Transaction in Own Shares

Showing 101–150 of 998 announcements

GSK PLC RNS

GSK PLC RNS